Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Thein Hlaing Oo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5201-731X; OpenAlex author ID A5038157897. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
4
Papers, trials and grants by year

2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 4

  1. Primary ambulatory thromboprophylaxis in patients with pancreatic cancer receiving chemotherapy: hope or hype? Last author DOI 10.1007/s00520-022-07138-8↗
  2. The Clinical Applicability of Primary Thromboprophylaxis in Ambulatory Patients With Pancreatic Cancer. Last author DOI 10.1097/mpa.0000000000001799↗
  3. Benefit and risk of primary thromboprophylaxis in ambulatory patients with advanced pancreatic cancer receiving chemotherapy: a systematic review and meta-anal… Last author DOI 10.1097/mbc.0000000000000413↗
  4. Comment on "Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial". Co-author DOI 10.1200/jco.2015.64.0466↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kyaw Lwin Aung · 2 shared papers, 2021–2022 · strength 0.40
  2. Thura Win Htut · 1 shared paper, 2022 · strength 0.22
  3. Lyndsey Sandow · 1 shared paper, 2021 · strength 0.17
  4. Nay Min Tun · 1 shared paper, 2016 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.